Lirametostat
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 206532

CAS#: 1621862-70-1

Description: Lirametostat, also known as CPI-1205 is a highly potent (biochemical IC50 = 0.002 μM, cellular EC50 = 0.032 μM) and selective inhibitor of EZH2. Upon oral administration, CPI-1205 selectively inhibits the activity of both wild-type and mutated forms of EZH2. Inhibition of EZH2 specifically prevents the methylation of histone H3 on lysine 27 (H3K27). This decrease in histone methylation alters gene expression patterns associated with cancer pathways and results in decreased proliferation of EZH2-expressing cancer cells.


Chemical Structure

img
Lirametostat
CAS# 1621862-70-1

Theoretical Analysis

MedKoo Cat#: 206532
Name: Lirametostat
CAS#: 1621862-70-1
Chemical Formula: C27H33F3N4O3
Exact Mass: 518.25
Molecular Weight: 518.581
Elemental Analysis: C, 62.54; H, 6.41; F, 10.99; N, 10.80; O, 9.26

Price and Availability

Size Price Availability Quantity
10mg USD 450 2 Weeks
25mg USD 750 2 Weeks
50mg USD 1350 2 Weeks
100mg USD 2250 2 Weeks
200mg USD 3950 2 Weeks
Bulk inquiry

Synonym: CPI-1205; CPI 1205; CPI1205; Lirametostat;

IUPAC/Chemical Name: (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide

InChi Key: HPODOLXTMDHLLC-QGZVFWFLSA-N

InChi Code: InChI=1S/C27H33F3N4O3/c1-16-13-23(37-4)21(25(35)32-16)14-31-26(36)24-18(3)34(22-8-6-5-7-20(22)24)17(2)19-9-11-33(12-10-19)15-27(28,29)30/h5-8,13,17,19H,9-12,14-15H2,1-4H3,(H,31,36)(H,32,35)/t17-/m1/s1

SMILES Code: C[C@@H](N1C2=C(C(C(NCC3=C(C=C(NC3=O)C)OC)=O)=C1C)C=CC=C2)C4CCN(CC(F)(F)F)CC4

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 518.58 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Vaswani RG, Gehling VS, Dakin LA, Cook A, Nasveschuk CG, Duplessis M, Iyer P,
Balasubramanian S, Zhao F, Good AC, Campbell R, Lee C, Cantone N, Cummings RT,
Normant E, Bellon SF, Albrecht BK, Harmange JP, Trojer P, Audia JE, Zhang Y,
Justin N, Chen S, Wilson J, Gamblin S. Identification of
(R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1
-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205),
a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for
Phase I Clinical Trials for B-Cell Lymphomas. J Med Chem. 2016 Oct 14. PubMed
PMID: 27739677.